Da. Hudson et al., One-stage immediate breast and nipple-areolar reconstruction with autologous tissue I: A preliminary report, ANN PL SURG, 45(5), 2000, pp. 471-476
This preliminary report discusses 7 patients with early breast cancer (mean
age, 48 years) who underwent one-stage breast reconstruction. Reconstructi
on was achieved using a deepithelialized transverse rectus abdominis muscul
ocutaneous (TRAM) flap placed in a pocket created by a skin-sparing mastect
omy. Areolar reconstruction is performed by harvesting the areola as a full
-thickness graft from the mastectomy specimen, and nipple reconstruction is
achieved with a CV flap (in zone II of the TRAM flap), which is deepitheli
alized and covered with a full-thickness graft from the areola. In all pati
ents a contralateral reduction or mastopexy was performed. Recent evidence
suggests that not all patients with early breast cancer have areolar involv
ement, and that certain prognostic factors can be used to predict the likel
ihood of tumor involvement. A number of large studies have shown that in pa
tients with early breast cancer, when the tumor is situated more than 5 cm
from the nipple-areolar complex, tumor involvement of the nipple-areolar co
mplex is most unlikely. No patients in this study had histological evidence
of nipple involvement by cancer. The aesthetic results were very satisfact
ory in 5 of 7 patients. One patient who developed sepsis of the TRAM flap h
ad an unsatisfactory result. The other complications that occurred were min
or and self-limiting, The advantages of single-stage breast reconstruction
are financial and psychological. In addition, the patient attains homogenou
s nipple-areolar reconstruction. Areolar reconstruction is achieved with th
e best possible option-areola, This preliminary report suggests that in a s
elect group of patients with early breast cancer, when the tumor is more th
an 5 cm from the nipple-areolar complex, the areola may be preserved. The a
esthetic results in these patients was considered satisfactory, However, lo
ng-term studies are required to confirm the oncological safety of this tech
nique.